Cargando…

Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy

Detalles Bibliográficos
Autores principales:	Zhou, Yihui, Gao, Xiaomeng, Yuan, Meng, Yang, Bo, He, Qiaojun, Cao, Ji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563611/ https://www.ncbi.nlm.nih.gov/pubmed/34744754 http://dx.doi.org/10.3389/fphar.2021.785732

Ejemplares similares

Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy
por: Zhou, Yihui, et al.
Publicado: (2021)

Bafetinib Suppresses the Transcription of PD-L1 Through c-Myc in Lung Cancer
por: Chen, Xi, et al.
Publicado: (2022)

Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets
por: Zeng, Chenming, et al.
Publicado: (2020)

WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit
por: Gao, Xiaomeng, et al.
Publicado: (2022)

Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy
por: Yuan, Tao, et al.
Publicado: (2018)

Challenges and Improvements of Novel Therapies for Ischemic Stroke
por: Yang, Lijun, et al.
Publicado: (2021)

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis
por: Wang, Jiaying, et al.
Publicado: (2019)

Corrigendum: Targeted therapy in cardiovascular disease: A precision therapy era
por: Xu, Mengda, et al.
Publicado: (2023)

The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer
por: Chen, Xuankun, et al.
Publicado: (2022)

Trametinib Inhibits the Growth and Aerobic Glycolysis of Glioma Cells by Targeting the PKM2/c-Myc Axis
por: Gao, Mingjun, et al.
Publicado: (2021)

Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
por: Wang, Xing, et al.
Publicado: (2023)

Corrigendum: Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023)

Corrigendum: Research advances in drug therapy of endometriosis
por: Shi, Jianyou, et al.
Publicado: (2023)

Corrigendum: Formulation and development of transferrin targeted solid lipid nanoparticles for breast cancer therapy
por: Bhagwat, Geeta S., et al.
Publicado: (2023)

Retroperitoneal fibrosis—the long and winding path
por: Suwathep, Perawish, et al.
Publicado: (2020)

New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases
por: Hong, Wenxiang, et al.
Publicado: (2022)

Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
por: Yuan, Tao, et al.
Publicado: (2023)

Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism
por: Zhou, Li, et al.
Publicado: (2017)

Corrigendum: Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance
por: Tian, Xiaohong, et al.
Publicado: (2015)

Corrigendum: Evaluation of herb–drug interaction between Danshen and rivaroxaban in rat and human liver microsomes
por: Wang, Xu, et al.
Publicado: (2022)

Corrigendum: Anakinra Therapy for Non-cancer Inflammatory Diseases
por: Cavalli, Giulio, et al.
Publicado: (2019)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

Corrigendum: Discoidin Domain Receptors: Potential Actors and Targets in Cancer
por: Rammal, Hassan, et al.
Publicado: (2016)

Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
por: Bartmann, Lisa, et al.
Publicado: (2020)

Gypenosides Attenuate Pulmonary Fibrosis by Inhibiting the AKT/mTOR/c-Myc Pathway
por: Liu, Suqing, et al.
Publicado: (2022)

SLC35B4 Stabilizes c-MYC Protein by O-GlcNAcylation in HCC
por: Jiang, Tao, et al.
Publicado: (2022)

Matrine, a potential c-Myc inhibitor, suppresses ribosome biogenesis and nucleotide metabolism in myeloid leukemia
por: Zhong, Wang-Jing, et al.
Publicado: (2022)

Corrigendum: Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes
por: Jin, Chao, et al.
Publicado: (2023)

Corrigendum: Inflammatory Stress Potentiates Emodin-Induced Liver Injury in Rats
por: Tu, Can, et al.
Publicado: (2021)

Corrigendum: Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions
por: Mazzari, Andre L. D. A., et al.
Publicado: (2015)

Corrigendum: Impact of kinase activating and inactivating patient mutations on binary PKA interactions
por: Röck, Ruth, et al.
Publicado: (2015)

Corrigendum: Paraptosis: a unique cell death mode for targeting cancer
por: Hanson, Sweata, et al.
Publicado: (2023)

Physiological Considerations for Modeling in vivo Antibody-Target Interactions
por: Dunlap, Tyler, et al.
Publicado: (2022)

Corrigendum: R-carvedilol, a potential new therapy for Alzheimer’s disease
por: Yao, Jinjing, et al.
Publicado: (2023)

Corrigendum: Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson’s disease with a deep learning algorithm
por: Yan, Yu-Chen, et al.
Publicado: (2023)

Corrigendum: Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia
por: Crocker, Candice E., et al.
Publicado: (2018)

Corrigendum: Gamma Tocotrienol Protects Mice From Targeted Thoracic Radiation Injury
por: Kumar, Vidya P., et al.
Publicado: (2021)

Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
por: He, Lili, et al.
Publicado: (2016)

Corrigendum: Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF–HuR complex
por: Zhu, Qi, et al.
Publicado: (2022)

Corrigendum: In utero therapy for congenital disorders using amniotic fluid stem cells
por: Ramachandra, Durrgah L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5cnkegv39dmdbegtn10ratr7tb